HPV Clearance and the Neglected Role of Stochasticity

PLoS Computational Biology

Volumn 11, Issue 3, 2015, Pages

  Ryser, Marc D ^a   Myers, Evan R ^b   Durrett, Rick ^a  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLONE CELLS; CYTOLOGY; DISEASES; DYNAMICS; IMMUNE SYSTEM; POPULATION STATISTICS; STOCHASTIC SYSTEMS; VIRUSES;

ADAPTIVE IMMUNE RESPONSE; CELL DYNAMICS; CELLULAR LEVELS; IMMUNE CAPACITY; IMMUNE RESPONSE; MECHANISTICS; OROPHARYNGEAL; POPULATION LEVELS; STOCHASTICITY; STOCHASTICS;

STEM CELLS;

ADOLESCENT; ADULT; ARTICLE; BASEMENT MEMBRANE; CELL CLONE; CELL DIVISION; CELL MIGRATION; CELL PROLIFERATION; CONDYLOMA ACUMINATUM; FEMALE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFERENTIAL STATISTICS; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; MOLECULAR DYNAMICS; MONTE CARLO METHOD; NONHUMAN; PARAMETRIC TEST; PREDICTION; PROBABILITY; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS EPITHELIUM; STEM CELL; STOCHASTIC MODEL; VIRAL CLEARANCE; VIRION; VIRUS CELL INTERACTION; WART VIRUS; BIOLOGICAL MODEL; COMPLICATION; EPITHELIUM; IMMUNOLOGY; MARKOV CHAIN; PAPILLOMAVIRUS INFECTION; STATISTICAL MODEL; T LYMPHOCYTE; VIROLOGY;

HUMAN PAPILLOMAVIRUS;

EPITHELIUM; FEMALE; HIV INFECTIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; PAPILLOMAVIRUS INFECTIONS; STOCHASTIC PROCESSES; T-LYMPHOCYTES;

EID: 84926292434     PISSN: 1553734X     EISSN: 15537358     Source Type: Journal    
DOI: 10.1371/journal.pcbi.1004113     Document Type: Article

References (53)

1. Crow JM, (2012) HPV: The global burden. Nature 488: S2–S3. doi: 10.1038/488S2a 22932437
2. Leemans CR, Braakhuis BJM, Brakenhoff RH, (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9–22. doi: 10.1038/nrc2982 21160525
3. Marur S, D’Souza G, Westra WH, Forastiere AA, (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11: 781–789. doi: 10.1016/S1470-2045(10)70017-6 20451455
4. Syrjanen K, Hakama M, Saarikoski S, Väyrynen M, Yliskoski M, et al. (1990) Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population. J Sex Transm Dis 17: 15–9. doi: 10.1097/00007435-199017010-00004
5. Rodríguez AC, Schiffman M, Herrero R, Wacholder S, Hildesheim A, et al. (2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J Natl Cancer Inst 100: 513–517. doi: 10.1093/jnci/djn044 18364507
6. Rodríguez AC, Schiffman M, Herrero R, Hildesheim A, Bratti C, et al. (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst 102: 315–324. doi: 10.1093/jnci/djq001 20157096
7. Woodman CB, Collins SI, Young LS, (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7: 11–22. doi: 10.1038/nrc2050 17186016
8. Vargas-Parada L, (2012) Pathology: three questions. Nature 488: S14–S15. doi: 10.1038/488S14a 22932435
9. Ahdieh L, Klein RS, Burk R, Cu-Uvin S, Schuman P, et al. (2001) Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 184: 682–690. doi: 10.1086/323081 11517428
10. Farhat S, Nakagawa M, Moscicki AB, (2009) Cell-mediated immune responses to human papillomavirus 16 E6 and E7 antigens as measured by IFN gamma ELISpot in women with cleared or persistent HPV infection. Int J Gynecol Cancer 19: 508. doi: 10.1111/IGC.0b013e3181a388c4 19509544
11. Stanley M, (2008) Immunobiology of HPV and HPV vaccines. Gynecol Oncol 109: S15–S21. doi: 10.1016/j.ygyno.2008.02.003 18474288
12. Carter JJ, Wipf GC, Hagensee ME, McKnight B, Habel LA, et al. (1995) Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis 172: 11–18. doi: 10.1093/infdis/172.1.11 7797899
13. Dillner J, (1999) The serological response to papillomaviruses. In: Seminars in cancer biology. Elsevier, volume 9, pp. 423–430.
14. Carter JJ, Koutsky LA, Wipf GC, Christensen ND, Lee SK, et al. (1996) The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 174: 927–936. doi: 10.1093/infdis/174.5.927 8896492
15. Robboy S, (2009) Robboy’s Pathology of the Female Reproductive Tract. Churchill Livingstone. Churchill Livingstone/Elsevier.
16. Doorbar J, (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clinical science 110: 525–541. doi: 10.1042/CS20050369 16597322
17. Alcolea MP, Jones PH, (2013) Tracking cells in their native habitat: lineage tracing in epithelial neoplasia. Nat Rev Cancer 13: 161–171. doi: 10.1038/nrc3460 23388619
18. Clayton E, Doupé D, Klein A, Winton D, Simons B, et al. (2007) A single type of progenitor cell maintains normal epidermis. Nature 446: 185–189. doi: 10.1038/nature05574 17330052
19. Doupé DP, Alcolea MP, Roshan A, Zhang G, Klein AM, et al. (2012) A single progenitor population switches behavior to maintain and repair esophageal epithelium. Science 337: 1091–1093. doi: 10.1126/science.1218835 22821983
20. Parkin DM, Bray F, (2006) The burden of hpv-related cancers. Vaccine 24: S11–S25. doi: 10.1016/j.vaccine.2006.05.111
21. Rautava J, Syrjänen S, (2012) Biology of human papillomavirus infections in head and neck carcinogenesis. Head Neck Pathol 6: 3–15. doi: 10.1007/s12105-012-0367-2
22. Stanley M, (2010) Pathology and epidemiology of HPV infection in females. Gynecol Oncol 117: S5–S10. doi: 10.1016/j.ygyno.2010.01.024 20304221
23. Herfs M, Yamamoto Y, Laury A, Wang X, Nucci MR, et al. (2012) A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer. P Natl Acad Sci USA 109: 10516–10521. doi: 10.1073/pnas.1202684109
24. Moscicki AB, Schiffman M, Kjaer S, Villa LL, (2006) Updating the natural history of HPV and anogenital cancer. Vaccine 24: S42–S51. doi: 10.1016/j.vaccine.2006.06.018
25. Stanley M, (2006) Immune responses to human papillomavirus. Vaccine 24: S16–S22. doi: 10.1016/j.vaccine.2005.09.002 16219398
26. Squier CA, Kremer MJ, (2001) Biology of oral mucosa and esophagus. J Natl Cancer Inst Monogr 2001: 7–15. doi: 10.1093/oxfordjournals.jncimonographs.a003443
27. Klein A, Doupé D, Jones P, Simons B, (2007) Kinetics of cell division in epidermal maintenance. Physical Review E 76: 021910. doi: 10.1103/PhysRevE.76.021910
28. Simons BD, Clevers H, (2011) Strategies for homeostatic stem cell self-renewal in adult tissues. Cell 145: 851–862. doi: 10.1016/j.cell.2011.05.033 21663791
29. Gaisa NT, Graham TA, McDonald SA, Cañadillas-Lopez S, Poulsom R, et al. (2011) The human urothelium consists of multiple clonal units, each maintained by a stem cell. J Pathol 225: 163–171. doi: 10.1002/path.2945 21744343
30. Stanley M, (2012) Epithelial cell responses to infection with human papillomavirus. Clin Microbiol Rev 25: 215–222. doi: 10.1128/CMR.05028-11 22491770
31. Jeon S, Allen-Hoffmann BL, Lambert PF, (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989–2997. 7707525
32. Harris T, (2002) The theory of branching processes. Dover Publications.
33. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. The Lancet 370: 890–907. doi: 10.1016/S0140-6736(07)61416-0
34. (2000) Adolescent Medicine HIV/AIDS Research Network. Reaching for Excellence in Adolescent Care and Health (REACH): 19962000. Brooklyn, NY: SUNY Health Sciences Center (Producer). Los Altos, CA: Sociometrics Corporation (Producer & Distributor). Computer file
35. Futterman M, Donna K, Moscicki M, Barbara A, Wilson M, et al. (1998) The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants. J Adolescent Health 22: 300–311. doi: 10.1016/S1054-139X(97)00279-6
36. Moscicki A, Ellenberg J, Farhat S, Xu J, (2004) Persistence of human papillomavirus infection in HIV-infected and-uninfected adolescent girls: risk factors and differences, by phylogenetic type. J Infect Dis 190: 37–45. doi: 10.1086/421467 15195241
37. Liu SH, Cummings DA, Zenilman JM, Gravitt PE, Brotman RM, (2014) Characterizing the temporal dynamics of human papillomavirus dna detectability using shortinterval sampling. Cancer Epidem Biomar 23: 200–208. doi: 10.1158/1055-9965.EPI-13-0666
38. Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, et al. (2010) Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women. Cancer Epidem Biomar 19: 1585–1594. doi: 10.1158/1055-9965.EPI-09-1235
39. Brown DR, Shew ML, Qadadri B, Neptune N, Vargas M, et al. (2005) A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J Infect Dis 191: 182–192. doi: 10.1086/426867 15609227
40. Maglennon G, McIntosh P, Doorbar J, (2014) Immunosuppression facilitates the reactivation of latent papillomavirus infections. J Virol 88: 710–716. doi: 10.1128/JVI.02589-13 24173230
41. Munoz N, Castellsagué X, de González AB, Gissmann L, (2006) HPV in the etiology of human cancer. Vaccine 24: S1–S10. doi: 10.1016/j.vaccine.2006.05.115
42. Chung SH, Shin MK, Korach KS, Lambert PF, (2013) Requirement for stromal estrogen receptor alpha in cervical neoplasia. Hormones and Cancer 4: 50–59. doi: 10.1007/s12672-012-0125-7 23065599
43. Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, et al. (2011) The antiproliferative action of progesterone in uterine epithelium is mediated by hand2. Science 331: 912–916. doi: 10.1126/science.1197454 21330545
44. Urban M, Banks E, Egger S, Canfell K, O’Connell D, et al. (2012) Injectable and oral contraceptive use and cancers of the breast, cervix, ovary, and endometrium in black south african women: case–control study. PLoS medicine 9: e1001182. doi: 10.1371/journal.pmed.1001182 22412354
45. The WHO Collaborative Study (1992) Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. Contraception 45: 299–312. doi: 10.1016/0010-7824(92)90052-U 1387601
46. Gravitt PE, (2011) The known unknowns of HPV natural history. J Clin Invest 121: 4593. doi: 10.1172/JCI57149 22133884
47. Maglennon GA, McIntosh P, Doorbar J, (2011) Persistence of viral DNA in the epithelial basal layer suggests a model for papillomavirus latency following immune regression. Virology 414: 153–163. doi: 10.1016/j.virol.2011.03.019 21492895
48. Doorbar J, (2013) Latent papillomavirus infections and their regulation. Curr Opin Virol 3: 416–421. doi: 10.1016/j.coviro.2013.06.003 23816390
49. Potten C, (1974) The epidermal proliferative unit: the possible role of the central basal cell. Cell Proliferat 7: 77–88. doi: 10.1111/j.1365-2184.1974.tb00401.x
50. Orlando PA, Gatenby RA, Giuliano AR, Brown JS, (2012) Evolutionary ecology of human papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J Infect Dis 205: 272–279. doi: 10.1093/infdis/jir717 22090448
51. Lía Murall C, McCann KS, Bauch CT, (2014) Revising ecological assumptions about human papillomavirus interactions and type replacement. J Theor Biol.
52. Klein AM, Doupé DP, Jones PH, Simons BD, (2008) Mechanism of murine epidermal maintenance: Cell division and the voter model. Phys Rev E 77: 031907. doi: 10.1103/PhysRevE.77.031907
53. Foo J, Leder K, Ryser MD, (2014) Multifocality and recurrence risk: a quantitative model of field cancerization. J Theor Biol 355: 170–184. doi: 10.1016/j.jtbi.2014.02.042 24735903